tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CRNX Stock Latest News

Crinetics Pharmaceuticals Outlines 2025 Strategic Priorities
Company AnnouncementsCrinetics Pharmaceuticals Outlines 2025 Strategic Priorities
4d ago
8K
CRNX
Crinetics data ‘compelling’ despite safety concerns, says Leerink
PremiumThe Fly
Crinetics data ‘compelling’ despite safety concerns, says Leerink
8d ago
CRNX
Crinetics CAH data ‘okay,’ but expectations were high, says Jefferies
PremiumThe Fly
Crinetics CAH data ‘okay,’ but expectations were high, says Jefferies
8d ago
CRNX
Crinetics Pharmaceuticals Advances Atumelnant After Successful Phase 2
PremiumCompany Announcements
Crinetics Pharmaceuticals Advances Atumelnant After Successful Phase 2
8d ago
8K
CRNX
Crinetics announces results from Phase 2 trial of atumelnant
PremiumThe Fly
Crinetics announces results from Phase 2 trial of atumelnant
8d ago
CRNX
Crinetics Pharmaceuticals Strengthens Leadership with New Appointment
PremiumCompany AnnouncementsCrinetics Pharmaceuticals Strengthens Leadership with New Appointment
1M ago
8K
CRNX
Crinetics appoints Isabel Kalofonos as CCO
Premium
The Fly
Crinetics appoints Isabel Kalofonos as CCO
1M ago
CRNX
Crinetics announces FDA acceptance of NDA for paltusotine
Premium
The Fly
Crinetics announces FDA acceptance of NDA for paltusotine
1M ago
CRNX
Crinetics price target raised to $87 from $80 at JMP Securities
PremiumThe Fly
Crinetics price target raised to $87 from $80 at JMP Securities
1M ago
CRNX
Crinetics price target raised to $74 from $70 at Citi
PremiumThe Fly
Crinetics price target raised to $74 from $70 at Citi
2M ago
CRNX
Crinetics price target raised to $81 from $69 at H.C. Wainwright
PremiumThe Fly
Crinetics price target raised to $81 from $69 at H.C. Wainwright
2M ago
CRNX
Crinetics Pharmaceuticals Announces Q3 2024 Financial Results
PremiumCompany Announcements
Crinetics Pharmaceuticals Announces Q3 2024 Financial Results
2M ago
CRNX
Crinetics reports Q3 EPS (96c), consensus (91c)
PremiumThe FlyCrinetics reports Q3 EPS (96c), consensus (91c)
2M ago
CRNX
CRNX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CRNX Upcoming Earnings Report: What to Expect?
2M ago
CRNX
3 Best Stocks to Buy Now, 10/15/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 10/15/2024, According to Top Analysts 
3M ago
CRNX
GRAB
Crinetics price target raised to $71 from $59 at JonesResearch
PremiumThe Fly
Crinetics price target raised to $71 from $59 at JonesResearch
3M ago
CRNX
Morning Movers: Arcadium Lithium surges after deal to be acquired
PremiumThe Fly
Morning Movers: Arcadium Lithium surges after deal to be acquired
3M ago
BA
DKL
Crinetics 10M share Spot Secondary priced at $50.00
PremiumThe Fly
Crinetics 10M share Spot Secondary priced at $50.00
3M ago
CRNX
Crinetics $400M Spot Secondary; price range $50.00-$51.00
PremiumThe Fly
Crinetics $400M Spot Secondary; price range $50.00-$51.00
3M ago
CRNX
Crinetics announces $400M common stock offering
PremiumThe FlyCrinetics announces $400M common stock offering
3M ago
CRNX
Crinetics submits NDA for paltusotine for treatment of Acro
Premium
The Fly
Crinetics submits NDA for paltusotine for treatment of Acro
4M ago
CRNX
Crinetics price target lowered to $73 from $74 at Oppenheimer
Premium
The Fly
Crinetics price target lowered to $73 from $74 at Oppenheimer
5M ago
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >